CD4-reactive antibodies in systemic lupus erythematosus

Human Immunology

Volumn 49, Issue 1, 1996, Pages 38-48

  Lenert, Petar ^a   Lenert, Gordana ^a   Senécal, Jean Luc ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DNA; DNA ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M; LYMPHOCYTE ANTIBODY;

ADULT; ANTIGEN ANTIBODY COMPLEX; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030018717     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/0198-8859(96)00058-4     Document Type: Article

References (47)

1. Avrameas S: Natural autoantibodies: from "horror autotoxicus" to "gnothi seauton." Immunol Today 12:154, 1991.
2. Kazatckine MD, Dietrich G, Hurez V, Ronda N, Bellon B, Rossi F, Kaveri SV: V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig). Imunol Rev 139:79, 1994.
3. Berneman A, Ternynck T, Avrameas S: Natural mouse IgG reacts with self antigens including molecules involved in the immune response. Eur J Immunol 22:625, 1992.
4. Lederman S, Yellin MJ, Cleary AM, Gulick R, Chess L: Recombinant, truncated CD4 molecule (rT4) binds IgG. J Immunol 144:214, 1990.
5. Lenert P, Kroon D, Spiegelberg H, Golub ES, Zanetti M: Human CD4 binds immunoglobulins. Science 248:1639, 1990.
6. Lenert P, Mehta RL, Zanetti M: Synthetic peptides of human CD4 enhance binding of Ig to monocyte/macrophage cells. I. Characterization and mapping studies. J Immunol 148:1759, 1992.
7. Mehta RL, Lenert P, Zanetti M: Synthetic peptides of human CD4 enhance binding of immunoglobulins to monocyte/macrophage cells. II. Mechanisms of enhancement. Cell Immunol 156:146, 1994.
8. Lenert P, Lenert G, Zanetti M: Human recombinant CD4 and CD4-derived synthetic peptides agglutinate immunoglobulin-coated latex particles: evidence that residues 25-28 and 35-38 of human CD4 form two separate immunoglobulin binding sites. Mol Immunol 32:1399, 1996.
9. Maddon PJ, Littman DR, Godfrey M, Maddon DE, Chess L, Axel R: The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell 42:93, 1985.
10. Janeway CA Jr: The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol 10:645, 1992.
11. Dianzani U, Shaw A, al-Ramadi BK, Kubo RT, Janeway CA Jr: Physical association of CD4 with the T cell receptor. J Immunol 148:678, 1992.
12. Doyle C, Strominger JL: Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330:256, 1987.
13. Gay D, Maddon P, Sékaly R, Talle MA, Godfrey M, Long E, Goldstein G, Chess L, Axel R, Kappler J, Marrack P. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature 328:626, 1987.
14. Bank I, Chess L: Perturbation of the T4 molecule transmits negative signal to T cells. J Exp Med 162:1294, 1985.
15. Diamond DC, Sleckman BP, Gregory T, Lasky LA, Greenstein JL, Burakoff SJ: Inhibition of CD4+ T cell function by the HIV envelope protein gp120. J Immunol 141:3715, 1988.
16. Mann DL, Lasane F, Popovic M, Arthur LO, Robey WG, Blattner WA, Newman MJ: HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol 138:2640, 1987.
17. Rosoff PM, Burakoff SJ, Greenstein JL: The role of the L3T4 molecule in mitogen and antigen-activated signal transduction. Cell 49:845, 1987.
18. Mittler RS, Hoffmann MK: Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Science 245:1380, 1989.
19. Winfield JB, Mimura T: Pathogenetic significance of anti-lymphocyte autoantibodies in systemic lupus erythematosus. Clin Immunol Immunopathol 63:13, 1992.
20. Denburg SD, Behmann SA, Carbotte RM, Denburg JA: Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 37:369, 1994.
21. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271, 1982.
22. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315, 1988.
23. Wilken N, Kossner U, Senécal J-L, Scheer U, Dabauvalle MC: Nup180, a nuclear pore complex protein localizing to the cytoplasmic ring and associated fibrils. J Cell Biol 123:1345, 1993.
24. Senécal J-L, Raymond Y: Autoantibodies to major and minor nuclear lamins are not restricted to autoimmune diseases. Clin Immunol Immunopathol 63:115, 1992.
25. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Committee on prognosis studies in SLE: Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35:630, 1992.
26. How A, Dent PB, Liao S-K, Denburg JA: Anti-neuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 28:789, 1985.
27. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350, 1979.
28. Friguet B, Chaffotte AF, Djavadi-Ohaniance L, Goldberg ME: Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 77:305, 1985.
29. Mimura T, Fernsten P, Jarjour W, Winfield JB: Autoantibodies specific for different isoforms of CD45 in systemic lupus erythematosus. J Exp Med 172:653, 1990.
30. Winfield JB, Shaw M, Yamada A, Minota S: Subset specificity of antilymphocyte antibodies in systemic lupus erythematosus. II. Preferential reactivity with T4+ cells is associated with relative depletion of autologous T4+ cells. Arthritis Rheum 30:162, 1987.
31. Lenert P, Zanetti M: CD4/immunoglobulin interaction: implications for immune physiology and autoimmunity. Int Rev Immunol 7:237, 1991.
32. Adib M, Ragimbeau J, Avrameas S, Ternynck T: IgG autoantibody activity in normal mouse serum is controlled by IgM. J Immunol 145:3807, 1990.
33. Lamarre D, Ashkenazi A, Fleury S, Smith DH, Sekaly R-P, Capon DJ: The MHC-binding and gp120-binding functions of CD4 are separable. Science 245:743, 1989.
34. Clayton LK, Sieh M, Pious DA, Reinherz EL: Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature 339:549, 1989.
35. Singh RR, Kumar V, Ebling FM, Southwood S, Sette A, Sercarz EE, Hahn BH: T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J Exp Med 181:2017, 1995.
36. Callahan LN, Roderiquez G, Mallinson M, Norcross MA: Analysis of HIV-induced autoantibodies to cryptic epitopes on human CD4. J Immunol 149:2194, 1992.
37. Silverman GJ, Sasano M, Wormsley SB: Age-associated changes in binding of human B lymphocytes to a VH3-restricted unconventional bacterial antigen. J Immunol 151:5840, 1993.
38. Sasano M, Burton DR, Silverman GJ: Molecular selection of human antibodies with an unconventional bacterial B cell antigen. J Immunol 151:5822, 1993.
39. Hillson JL, Karr NS, Oppliger IR, Mannik M, Sasso EH: The structural basis of germline-encoded VH3 immunoglobulin binding of staphylococcal protein A. J Exp Med 178:331, 1993.
40. H3 family antibodies bind domain D of staphylococcal protein A. J Immunol 154:6437, 1995.
41. Herzenberg LA, Herzenberg LA: Toward a layered immune system. Cell 59:953, 1989.
42. Terasaki PL, Mottironi VD, Barnett EV: Cytotoxins in disease: autocytotoxins in lupus. N Engl J Med 283:724, 1970.
43. Sekigawa I, Groopmen JE, Allan JD, Ikeuchi K, Biberfield G, Takatsuki K, Byrn RA: Characterization of autoantibodies to the CD4 molecule in human immunodeficiency virus infection. Clin Immunol Immunopathol 58:145, 1991.
44. Wilks D, Walker LC, Habeshaw JA, Youle M, Gazzard B, Dalgleish AG: Anti-CD4 autoantibodies and screening for anti-idiotypic antibodies to anti-CD4 monoclonal antibodies in HIV-seropositive people. AIDS 4:113, 1990.
45. Corre J-P, Fevrier M, Chamaret S, Theze J, Zouali M: Anti-idiotypic antibodies to human anti-gp120 antibodies bind recombinant and cellular human CD4. Eur J Immunol 21:743, 1991.
46. Chams V, Idziorek T, Klatzmann D: Biological properties of anti-CD4 autoantibodies purified from HIV-infected patients. AIDS 5:565, 1991.
47. Butler WT, Sharp JT, Rossen RD, Lidsky MD, Mittal KK, Gard DA: Relationship of the clinical course of systemic lupus erythematosus to the presence of circulating lymphocytotoxic antibodies. Arthritis Rheum 15:231, 1972.